Clover Biopharmaceuticals, Ltd.
Status: Publicly traded
Direct answer
Clover Biopharmaceuticals, Ltd. is publicly traded on HKSE under the ticker 2197.HK.
Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on discovering, developing, and commercializing innovative vaccines and biological therapies. Their efforts target infectious diseases, various cancers, and autoimmune conditions. The company's pipeline features several key candidates: SCB-2019 (CpG 1018/Alum): A COVID-19 vaccine candidate currently advancing through Phase II/III clinical trials....
Can you invest in Clover Biopharmaceuticals, Ltd.?
Yes. Clover Biopharmaceuticals, Ltd. trades publicly on HKSE as 2197.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Clover Biopharmaceuticals, Ltd.
Detailed equity research is provided by MarketSnap.